Nath Bio-Genes (India) Ltd
Incorporated in 1993, Nath Bio-Genes Ltd
is in the business of Production, Processing,
and Marketing of Hybrid and GM Seeds[1]
- Market Cap ₹ 291 Cr.
- Current Price ₹ 153
- High / Low ₹ 239 / 138
- Stock P/E 6.17
- Book Value ₹ 362
- Dividend Yield 1.30 %
- ROCE 7.35 %
- ROE 6.77 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.42 times its book value
Cons
- The company has delivered a poor sales growth of 1.50% over past five years.
- Tax rate seems low
- Company has a low return on equity of 6.44% over last 3 years.
- Contingent liabilities of Rs.89.3 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 136 | 143 | 127 | 142 | 171 | 206 | 246 | 271 | 230 | 234 | 248 | 265 | 406 | |
| 102 | 109 | 103 | 113 | 131 | 163 | 191 | 204 | 193 | 185 | 197 | 212 | 349 | |
| Operating Profit | 34 | 35 | 25 | 29 | 40 | 43 | 55 | 67 | 37 | 49 | 50 | 53 | 57 |
| OPM % | 25% | 24% | 19% | 20% | 24% | 21% | 22% | 25% | 16% | 21% | 20% | 20% | 14% |
| 1 | 1 | 1 | 0 | 1 | 2 | 2 | 2 | -87 | 1 | 4 | 4 | 11 | |
| Interest | 4 | 5 | 6 | 10 | 10 | 5 | 7 | 9 | 11 | 10 | 9 | 10 | 11 |
| Depreciation | 5 | 4 | 4 | 3 | 1 | 1 | 1 | 3 | 3 | 3 | 3 | 4 | 4 |
| Profit before tax | 26 | 26 | 15 | 17 | 30 | 39 | 49 | 57 | -63 | 36 | 42 | 44 | 53 |
| Tax % | 5% | 4% | 6% | 3% | 2% | 1% | -4% | 2% | 6% | 3% | 5% | 4% | |
| 24 | 25 | 14 | 16 | 29 | 38 | 50 | 56 | -67 | 35 | 40 | 42 | 50 | |
| EPS in Rs | 15.18 | 15.87 | 8.85 | 10.17 | 15.48 | 20.22 | 26.56 | 29.29 | -35.43 | 18.51 | 21.14 | 22.17 | 26.20 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 7% | -6% | 11% | 9% | 9% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 2% |
| 3 Years: | 5% |
| TTM: | 16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | -3% |
| 3 Years: | 21% |
| TTM: | 16% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | -11% |
| 3 Years: | -4% |
| 1 Year: | -21% |
| Return on Equity | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 7% |
| 3 Years: | 6% |
| Last Year: | 7% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 16 | 16 | 16 | 16 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 |
| Reserves | 66 | 91 | 105 | 287 | 450 | 489 | 539 | 594 | 523 | 554 | 592 | 630 | 668 |
| 23 | 22 | 59 | 74 | 33 | 58 | 70 | 101 | 93 | 105 | 108 | 111 | 142 | |
| 85 | 97 | 87 | 78 | 69 | 80 | 102 | 75 | 105 | 114 | 158 | 257 | 176 | |
| Total Liabilities | 190 | 226 | 267 | 455 | 571 | 646 | 730 | 790 | 740 | 793 | 877 | 1,017 | 1,005 |
| 17 | 13 | 30 | 207 | 211 | 232 | 246 | 247 | 245 | 244 | 249 | 250 | 249 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 6 |
| 168 | 208 | 231 | 243 | 355 | 409 | 479 | 538 | 490 | 544 | 622 | 761 | 750 | |
| Total Assets | 190 | 226 | 267 | 455 | 571 | 646 | 730 | 790 | 740 | 793 | 877 | 1,017 | 1,005 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15 | 6 | -14 | 3 | -47 | -23 | 9 | 1 | 17 | 38 | 75 | 27 | |
| -16 | -2 | -17 | -4 | -4 | -20 | -14 | -10 | -20 | -3 | -27 | -4 | |
| 1 | -4 | 30 | 5 | 90 | 20 | 6 | 16 | -22 | -2 | -10 | -11 | |
| Net Cash Flow | -0 | -1 | -0 | 5 | 39 | -23 | 1 | 7 | -25 | 34 | 38 | 12 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 95 | 114 | 130 | 133 | 175 | 191 | 159 | 147 | 136 | 152 | 139 | 122 |
| Inventory Days | 3,840 | 4,743 | 4,388 | |||||||||
| Days Payable | 1,309 | 1,406 | 586 | |||||||||
| Cash Conversion Cycle | 95 | 114 | 130 | 2,665 | 3,512 | 191 | 159 | 147 | 136 | 3,954 | 139 | 122 |
| Working Capital Days | 126 | 190 | 259 | 273 | 447 | 442 | 416 | 450 | 427 | 416 | 343 | 316 |
| ROCE % | 33% | 26% | 14% | 10% | 9% | 8% | 9% | 10% | 5% | 7% | 7% | 7% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript 18 Nov
-
Announcement under Regulation 30 (LODR)-Investor Presentation
14 Nov - Investor Presentation on financial results as on 30th September 2025.
-
Financial Results As On 30Th September 2025
13 Nov - Board approved Q2/H1 unaudited results for quarter/half-year ended 30 Sep 2025; limited review reports attached.
-
Board Meeting Outcome for Outcome Of Board Meeting
13 Nov - Board approved standalone and consolidated unaudited results for quarter and half-year ended 30 Sep 2025; limited review reports attached.
-
Intimation Of Earning Conference Call
10 Nov - Q2 & H1FY26 earnings conference call on Nov 14, 2025 at 12:30 PM IST.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
Concalls
-
Nov 2025Transcript PPT
-
Jul 2025TranscriptAI SummaryPPT
-
May 2025Transcript PPT REC
-
Jan 2025TranscriptAI SummaryPPT
-
Oct 2024Transcript PPT
-
Aug 2024TranscriptAI SummaryPPT
-
May 2024Transcript PPT REC
-
Jan 2024TranscriptAI SummaryPPT
-
Oct 2023Transcript PPT
-
Aug 2023TranscriptAI SummaryPPT
-
Apr 2023Transcript PPT
-
Feb 2023TranscriptAI SummaryPPT
-
Oct 2022TranscriptAI SummaryPPT
-
Aug 2022TranscriptAI SummaryPPT
-
Jun 2022Transcript PPT
-
Feb 2022TranscriptAI SummaryPPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jul 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Aug 2020Transcript PPT
-
Jun 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Nov 2019TranscriptPPT
-
Aug 2019Transcript PPT
-
May 2019TranscriptAI SummaryPPT
-
Apr 2019TranscriptAI SummaryPPT
-
Sep 2018TranscriptAI SummaryPPT
-
Nov 2017TranscriptAI SummaryPPT
Business Overview:[1][2][3]
NBGL is a flagship company of Nath Group.
It is an agri-tech company in the business of developing and supplying quality BT, hybrid, and varietal seeds to farmers at affordable prices. It does the production and processing of commercial and vegetable seeds on lands taken on lease from various growers /farmers throughout India. The company enters into seed production agreements with these farmers/growers and compensates them for various cultivation expenses based on the rate agreement entered into